scientists at yale university in connecticut in the us have revealed how the treatment , called azdo5030 , restored memory in mice given alzheimer's disease . the drug was developed by the british pharmaceutical giant astra zeneca with the original aim of treating certain types of tumour , but was shelved after it proved ineffective . scientists at yale university in connecticut in the us have revealed how the treatment , called azdo5030 , restored memory in mice given alzheimer's disease . researchers say the study drug has worked led by to blocking the a launch process of that human breaks trials nerve to connections test in the efficacy of the brain drug used in to alzheimer's store patients memory . 